牡丹江医科大学学报

参考文献

[1] FREDDIE B,JACQUES F,ISABELLE S,et al.Global Cancer Statistics 2018:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.

[2] QURESHI R,ARORA H,RIZVI M A.EMT in cervical cancer:Its role in tumour progression and response to therapy[J].Cancer Lett,2015,356(2):321-331.

[3] PENG J,QI S,WANG P,et al.Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for ervical cancer[J].Future Oncol,2016,12(5):715-726.

[4] YUE B,QIU S,ZHAO S,et al.LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis[J].J Gastroenterol Hepatol,2016,31(3):595-603.

[5] ALMEIDA P R,FERREIRA V A,ANTOS C C,et al.E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes[J].J Clin Pathol,2010,63(7):635-639.

[6] COLáS N,MILLáN J.How many cadherins do human endothelial cells express?[J].Cell Mol Life Sci,2019,76(7):1299-1317.

[7] KIM N G,KOH E,CHEN X,et al.E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathwaycomponents[J].Proc Natl Acad Sci USA,2011,108(29):11930-11935.

[8] NAVARRO P,GOMEZ M,PIZARRO A,et al.A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis[J].J Cell Biol,1991,115(2):517-533.

[9] LU T,MA K,ZHAN C,et al.Downregulation of long non-coding RNA LINP1 inhibits the malignant progression of esophageal squamous cell carcinoma[J].Ann Transl Med,2020,8(11):675.

[10] ZHAI J,YANG X,ZHANG Y,et a1.Reduced expression levels of the death associated protein kinase and E-cadherin are correlated with the development of esophageal squamous cell carcinoma[J].Exp Ther Med,2013,5(3):972-976.

[11] LUO KJ,HU Y,WEN J,et al.CyclinD1,p53,E-cadherin,and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma:a tissue array analysis[J].J Surg Oncol,2011,104(3):236.

[12] ISHIGURO H,WAKASUGL T,TERASHITA Y,et al.Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer[J].World J Surg Oncol,2016,14(1):240.

[13] YUAN W,LI T,MO X,et al.Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway[J].Oncotarget,2016,7(20):29507-29519.

[14] CHEN Y,KINGHAM K,FORD J M,et al.A prospective study of total gastrectomy for CDH1-positive herditary diffuse gastric cancer[J].Ann Surg Oncol,2011,18(9):2594-2598.

[15] MAEDA S,NAKAGAWA H.Roles of E-cadherin in Hepatocarcinogenesis[J].Innovative Medicine:Basic Research and Development,2015,23(6):71-77.

[16] CHEN J,ZHAO J,MA R,et al.Prognostic significance of E-cadherin expression in hepatocellular carcinoma:a meta-analysis[J].PLoS One,2014,9(8):e103952.

[17] TANG X,ZHANG W,YE Y,et al.LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma[J].Biomed Res Int,2020,98(4):9515-9519.

[18] NIKNAMI Z,MUHAMMADNEJAD A,EBRAHIMI A,et al.Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis[J].EXCLI J,2020,19(6):917-926.

[19] HE X,CHEN Z,JIA M,et al.Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer:evidence from meta-analysis[J].PLoS One,2013,8(7):708-712.

[20] MUHAMMAD B A,ALMAN U I,JONG K S,et al.PRP4 Kinase Domain Loss Nullifies Drug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells[J].Mol Cells,2020,43(7):662-670.